FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126113007: Medroxyprogesterone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
12707014 Medroxyprogesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730034012 Medroxyprogesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
54651000195110 medrossiprogesterone acetato it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
823181000172117 médroxyprogestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69021000195117 Medroxyprogesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medroxyprogesterone Is a Progesterone false Inferred relationship Some
Medroxyprogesterone Is a Synthetic progestogen (substance) true Inferred relationship Some
Medroxyprogesterone Is a allergène médicamenteux false Inferred relationship Some
Medroxyprogesterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Medroxyprogesterone Is a Steroid hormone true Inferred relationship Some
Medroxyprogesterone Is a Pregnane (substance) true Inferred relationship Some
Medroxyprogesterone Is a Progestational hormone false Inferred relationship Some
Medroxyprogesterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Medroxyprogesterone acetate Is a False Medroxyprogesterone Inferred relationship Some
Medroxyprogesterone adverse reaction Causative agent (attribute) True Medroxyprogesterone Inferred relationship Some 1
Allergy to medroxyprogesterone Causative agent (attribute) False Medroxyprogesterone Inferred relationship Some
Product containing medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Medroxyprogesterone-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Product containing medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Medroxyprogesterone 150mg/ml injection 1ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Medroxyprogesterone acetate 150mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Estrogens, conjugated+medroxyprogesterone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing conjugated estrogen and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Allergy to medroxyprogesterone Causative agent (attribute) True Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone Inferred relationship Some 2
Medroxyprogesterone acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone Inferred relationship Some
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone Inferred relationship Some 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone Inferred relationship Some 2
Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone Inferred relationship Some 2
Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone Inferred relationship Some 2
Product containing estradiol and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Estradiol- and medroxyprogesterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Product containing only conjugated estrogen and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 2
Estradiol and medroxyprogesterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Product containing only medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Medroxyprogesterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Conjugated estrogen and medroxyprogesterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 2
Medroxyprogesterone only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 3
Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 3
Conjugated estrogen- and esterified estrogen- and medroxyprogesterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 3
Conjugated estrogen and esterified estrogen and medroxyprogesterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 3
Estradiol and medroxyprogesterone only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1
Estradiol- and medroxyprogesterone-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Medroxyprogesterone Inferred relationship Some 1

This concept is not in any reference sets

Back to Start